Status:

TERMINATED

Diabetic Gastroparesis Study 05

Lead Sponsor:

Allergan

Conditions:

Gastroparesis

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This open-label study is to assess the safety of continued treatment with relamorelin for participants who previously completed the RLM-MD-03 \[NCT03420781\] or RLM-MD-04 \[NCT03383146\] study and to ...

Eligibility Criteria

Inclusion

  • Successful completion of either Study RLM-MD-03 or Study RLM-MD-04
  • Ability to provide written informed consent (IC) prior to any study procedures and willingness and ability to comply with study procedures
  • Demonstration of adequate compliance with the study procedures in Study RLM-MD-03 or RLM-MD-04, in the opinion of the investigator.

Exclusion

  • Participant is planning to receive an investigational drug (other than study intervention) or investigational device at any time during Study 3071-305-020
  • Participant has an unresolved adverse event (AE) from a lead-in study, ie, a clinically significant finding on physical examination, clinical laboratory test, or 12-lead electrocardiogram (ECG) that, in the investigator's opinion, would limit the participant's ability to participate in or complete the study
  • Any other reason that, in the investigator's opinion, would confound proper interpretation of the study or expose a participant to unacceptable risk, including renal, hepatic, or cardiopulmonary disease
  • Females who are pregnant, nursing, or planning a pregnancy during the study.

Key Trial Info

Start Date :

December 20 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 5 2020

Estimated Enrollment :

202 Patients enrolled

Trial Details

Trial ID

NCT03786380

Start Date

December 20 2018

End Date

October 5 2020

Last Update

December 15 2021

Active Locations (486)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 122 (486 locations)

1

Pinnacle Research Group

Anniston, Alabama, United States, 36207

2

North Alabama Research Center, LLC

Athens, Alabama, United States, 35611

3

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35295

4

Digestive Health Specialist of the South East

Dothan, Alabama, United States, 36305